These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20059453)

  • 1. The prefrontal cortex: a target for antipsychotic drugs.
    Artigas F
    Acta Psychiatr Scand; 2010 Jan; 121(1):11-21. PubMed ID: 20059453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex.
    Amargós-Bosch M; Adell A; Artigas F
    J Neurochem; 2007 Jul; 102(2):550-61. PubMed ID: 17394545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action.
    Di Pietro NC; Seamans JK
    Pharmacopsychiatry; 2007 Dec; 40 Suppl 1():S27-33. PubMed ID: 18080940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action.
    Mocci G; Jiménez-Sánchez L; Adell A; Cortés R; Artigas F
    Neuropharmacology; 2014 Apr; 79():49-58. PubMed ID: 24211653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.
    Santana N; Mengod G; Artigas F
    Cereb Cortex; 2009 Apr; 19(4):849-60. PubMed ID: 18689859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of dopamine-induced depolarization of prefrontal cortical neurons.
    Shi WX; Zheng P; Liang XF; Bunney BS
    Synapse; 1997 Aug; 26(4):415-22. PubMed ID: 9215600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
    Lidow MS; Goldman-Rakic PS
    J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-based parametric study of frontostriatal abnormalities in schizophrenia patients.
    Tanaka S
    BMC Psychiatry; 2010 Feb; 10():17. PubMed ID: 20187970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine neurotransmission and atypical antipsychotics in prefrontal cortex: a critical review.
    Masana M; Santana N; Artigas F; Bortolozzi A
    Curr Top Med Chem; 2012; 12(21):2357-74. PubMed ID: 23279176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of atypical and typical antipsychotic drugs on N-methyl-D-aspartate- and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex.
    Ninan I; Jardemark KE; Wang RY
    Synapse; 2003 May; 48(2):66-79. PubMed ID: 12619040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Messing up with traffic: different effects of antipsychotic agents on glutamate receptor complexes in vivo.
    Del'guidice T; Beaulieu JM
    Mol Pharmacol; 2008 May; 73(5):1339-42. PubMed ID: 18314495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
    J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanism of action.
    Maheux J; Ethier I; Rouillard C; Lévesque D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):460-73. PubMed ID: 15615863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs.
    Lidow MS; Elsworth JD; Goldman-Rakic PS
    J Pharmacol Exp Ther; 1997 Apr; 281(1):597-603. PubMed ID: 9103549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic drugs and their action on different neuronal pathways.
    Ungerstedt U; Herrera-Marschitz M; Forster C
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.
    Santana N; Bortolozzi A; Serrats J; Mengod G; Artigas F
    Cereb Cortex; 2004 Oct; 14(10):1100-9. PubMed ID: 15115744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postsynaptic excitation of prefrontal cortical pyramidal neurons by hypocretin-1/orexin A through the inhibition of potassium currents.
    Xia J; Chen X; Song C; Ye J; Yu Z; Hu Z
    J Neurosci Res; 2005 Dec; 82(5):729-36. PubMed ID: 16247802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
    Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.